Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-02-24 @ 8:27 AM
Study NCT ID:
NCT02971293
Status:
COMPLETED
Last Update Posted:
2019-06-18
First Post:
2016-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Obstructive Pulmonary Disease COPD | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | AZD8871 | View |
| None | long-acting muscarinic antagonist (LAMA) | View |
| None | long-acting β2-agonist (LABA) | View |
| None | inhaled long-acting bronchodilator | View |
| None | pharmacokinetics | View |
| None | safety | View |
| None | tolerability | View |
| None | efficacy | View |
| None | Phase IIa | View |
| None | Muscarinic receptor antagonist β2 adrenoceptor agonist (MABA) | View |